Patient flow through the study
Budesonide 3 mg | Budesonide 9 mg | Prednisolone 7.5 mg | Placebo | Total | |
---|---|---|---|---|---|
Of 150 patients enrolled, five were not randomised because they were ineligible and two for other reasons. | |||||
*Five patients had two reasons for discontinuation. | |||||
Randomised | 37 | 36 | 39 | 31 | 143 |
Lost to follow up | 0 | 1 | 0 | 0 | 1 |
Included in intention to treat analysis | 37 | 35 | 39 | 31 | 142 |
Discontinued study medication | 7 | 6 | 3 | 7 | 23 |
Symptom deterioration* | 5 | 3 | 1 | 3 | 12 |
Adverse event* | 1 | 2 | 1 | 2 | 6 |
Other reasons* | 3 | 0 | 1 | 2 | 6 |
Completed study medication | 30 | 30 | 36 | 24 | 120 |